Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Exp Mol Pathol. 2015 Mar 18;98(3):491–501. doi: 10.1016/j.yexmp.2015.03.020

Figure 4. Effects of IFN-γ on APOL1 expression in HSMCs.

Figure 4

A. SMCs were treated with recombinant human IFN-γ for 36 hours at the concentrations indicated (n=3). Protein blots were probed for APOL1 and the same blots were stripped and reprobed for actin.

B. Cumulative densitometric data shown in bar graphs. * p < 0.05 compared with control.

SMCs were treated with 10 ng/ml of recombinant human IFN-γ for the indicated time periods (n=3). Subsequently, cells and incubation media were harvested.

C. Protein blots were probed for APOL1, stripped and reprobed for actin.

D. Cumulative densitometric analysis shown in a bar diagram. * p < 0.05 compared with 0, 12, 48, and 72 h.

E. APOL1 concentrations in incubation media were determined by ELISA. * p < 0.05 compared with control.